Viatris (VTRS) Competitors

Viatris (NASDAQ:VTRS) and argenx (NASDAQ:ARGX) are both large-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, media sentiment, institutional ownership, risk, dividends, community ranking, analyst recommendations, earnings and valuation.

Which has preferable valuation and earnings, VTRS or ARGX?

Viatris has higher revenue and earnings than argenx. Viatris is trading at a lower price-to-earnings ratio than argenx, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Viatris	$14.74B	0.68	$54.70M	-$0.53	-15.89
argenx	$2.19B	17.99	-$295.05M	$12.59	51.24

Do analysts recommend VTRS or ARGX?

Viatris currently has a consensus price target of $10.50, suggesting a potential upside of 24.70%. argenx has a consensus price target of $699.28, suggesting a potential upside of 8.39%. Given Viatris' higher possible upside, research analysts clearly believe Viatris is more favorable than argenx.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Viatris	2 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.75
argenx	0 Sell rating(s)	3 Hold rating(s)	19 Buy rating(s)	1 Strong Buy rating(s)	2.91

Does the media prefer VTRS or ARGX?

In the previous week, Viatris had 19 more articles in the media than argenx. MarketBeat recorded 40 mentions for Viatris and 21 mentions for argenx. argenx's average media sentiment score of 1.18 beat Viatris' score of 0.02 indicating that argenx is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Viatris	0 Very Positive mention(s)	6 Positive mention(s)	29 Neutral mention(s)	2 Negative mention(s)	2 Very Negative mention(s)	Neutral
argenx	14 Very Positive mention(s)	2 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Is VTRS or ARGX more profitable?

argenx has a net margin of -2.11% compared to Viatris' net margin of -5.87%. Viatris' return on equity of 16.46% beat argenx's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Viatris	-5.87%	16.46%	7.09%
argenx	-2.11%	-1.45%	-1.29%

Do institutionals & insiders have more ownership in VTRS or ARGX?

79.9% of Viatris shares are held by institutional investors. Comparatively, 60.3% of argenx shares are held by institutional investors. 0.1% of Viatris shares are held by insiders. Comparatively, 2.4% of argenx shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Which has more volatility and risk, VTRS or ARGX?

Viatris has a beta of 0.91, indicating that its stock price is 9% less volatile than the S&P 500. Comparatively, argenx has a beta of 0.6, indicating that its stock price is 40% less volatile than the S&P 500.

Does the MarketBeat Community favor VTRS or ARGX?

argenx received 634 more outperform votes than Viatris when rated by MarketBeat users. Likewise, 67.38% of users gave argenx an outperform vote while only 34.85% of users gave Viatris an outperform vote.

Company	Underperform	Outperform
Viatris	Outperform Votes 23 34.85%	Underperform Votes 43 65.15%
argenx	Outperform Votes 657 67.38%	Underperform Votes 318 32.62%

Summary

argenx beats Viatris on 10 of the 19 factors compared between the two stocks.